The University of Texas Health Science Center at Houston
BS
Biology and Chemistry
Our Lady of the Lake University
Research and Expertise
Research Interests
The majority of Dr. Galloway-Pena's studies have incorporated the genetic basis of pathogenesis as well as the molecular epidemiology of clinically relevant gram-positive pathogens, focusing on those with multi-drug resistance. She has more recently shifted her focus to microbiome dynamics during cancer therapy and the microbiome's impact on cancer treatment outcomes and toxicities. Clinical applications of her research include determining genetic and chemical markers for microbial diversity that can be used in the clinical setting, designing predictive risk models for toxicity risk during chemotherapy, and promoting antimicrobial stewardship and microbial conscious treatments during cancer therapy.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.